N/A
N=412
Group Therapy for Nicotine Dependence: Mindfulness and Smoking
Smoking · Tobacco Use Cessation
Bottom Line
View on ClinicalTrials.gov: NCT00297479 ↗Enrolled (actual)
412
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcome: Primary: Number of Participants With Smoking Abstinence — 21; 39; 43 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MBAT Group Therapy (Behavioral); Nicotine (Drug); Group Therapy (Behavioral); Individual Therapy (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- M.D. Anderson Cancer Center
- Primary completion
- Sep 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Smoking Abstinence |
21; 39; 43 | — |
| PRIMARY Smoking Abstinence |
12; 24; 53 | — |
| PRIMARY Smoking Abstinence |
12; 24; 53 | — |
Summary
The goal of this behavioral research study is to create and study a Mindfulness-Based Addiction Treatment (MBAT) for nicotine dependence. Mindfulness is a method to help focus attention on being in the "here and now." It can be learned through training in how to control one's attention. It is usually taught through meditation. The overarching goals of the study are to evaluate the efficacy of MBAT for nicotine dependence and the mechanisms and effects posited to mediate MBAT's impact on abstinence.
Eligibility Criteria
Inclusion Criteria
- Age 18 or above
- Current smoker with a history of at least five cigarettes/day for the past year
- Motivated to quit within the next 30 days (preparation stage)
- Participants must provide a viable home address and a functioning home telephone number
- Can read and write in English
- Register "8" or more on a carbon monoxide breath test
- Provide viable collateral contact information
Exclusion Criteria
- Contraindication for nicotine patch use
- Regular use of tobacco products other than cigarettes (cigars, pipes, smokeless tobacco)
- Use of bupropion or nicotine patch replacement products other than the study patches
- Pregnancy or lactation
- Another household member enrolled in the study
- Active substance dependence (exclusive of nicotine dependence)
- Current psychiatric disorder; current use of psychotropic medication
- Participation in a smoking cessation program or study during the past 90 days
Data sourced from ClinicalTrials.gov (NCT00297479). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.